Matches in Wikidata for { <http://www.wikidata.org/entity/Q92029373> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q92029373 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92029373 description "scientific article published on 14 May 2019" @default.
- Q92029373 description "wetenschappelijk artikel" @default.
- Q92029373 description "наукова стаття, опублікована 14 травня 2019" @default.
- Q92029373 name "Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction for Fesoterodine When Coadministered With Mirabegron" @default.
- Q92029373 name "Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction for Fesoterodine When Coadministered With Mirabegron" @default.
- Q92029373 type Item @default.
- Q92029373 label "Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction for Fesoterodine When Coadministered With Mirabegron" @default.
- Q92029373 label "Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction for Fesoterodine When Coadministered With Mirabegron" @default.
- Q92029373 prefLabel "Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction for Fesoterodine When Coadministered With Mirabegron" @default.
- Q92029373 prefLabel "Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction for Fesoterodine When Coadministered With Mirabegron" @default.
- Q92029373 P1433 Q92029373-FF15B4F8-FB46-49E0-B9BE-36D922A90A58 @default.
- Q92029373 P1476 Q92029373-CAD122D2-21DA-42B4-BDBB-48985F133C80 @default.
- Q92029373 P2093 Q92029373-02416C09-4DF5-47DB-9E91-1868782F0F4B @default.
- Q92029373 P2093 Q92029373-024231F7-C119-43BD-8BE8-6EA2569A70C7 @default.
- Q92029373 P2093 Q92029373-9E3A4481-125C-45A8-ACBE-3277A889842D @default.
- Q92029373 P2093 Q92029373-B207F085-2B59-4C13-AE4F-69AB2B2D0195 @default.
- Q92029373 P2093 Q92029373-F324B31F-B981-47E5-92B1-11C656867B63 @default.
- Q92029373 P304 Q92029373-487E9944-52E6-4CDE-8C89-616320B30DBE @default.
- Q92029373 P31 Q92029373-75086A7B-78B9-48D2-89D3-D525F63EE6A0 @default.
- Q92029373 P356 Q92029373-6E724695-7B0A-47C8-B318-27AD5E93D6C7 @default.
- Q92029373 P433 Q92029373-EA6D0A34-793F-4B91-B170-FD461CB246F0 @default.
- Q92029373 P478 Q92029373-3A667747-88EE-4FA4-9A28-45E85A1B2A86 @default.
- Q92029373 P577 Q92029373-AEFE8C57-A4FF-4961-8DB7-0173AAD019C7 @default.
- Q92029373 P698 Q92029373-0C7CF989-A0B3-4A8D-AD6D-B2E1FAF11C7B @default.
- Q92029373 P921 Q92029373-45BBED55-E256-46C3-A7C9-BC15E93A47A8 @default.
- Q92029373 P921 Q92029373-5A684060-B405-4A8D-BF66-B875AD3008D7 @default.
- Q92029373 P356 JCPH.1438 @default.
- Q92029373 P698 31090092 @default.
- Q92029373 P1433 Q7743562 @default.
- Q92029373 P1476 "Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction for Fesoterodine When Coadministered With Mirabegron" @default.
- Q92029373 P2093 "Bimal Malhotra" @default.
- Q92029373 P2093 "Hidetomi Yamagami" @default.
- Q92029373 P2093 "Jian Lin" @default.
- Q92029373 P2093 "Susanna Tse" @default.
- Q92029373 P2093 "Theunis C Goosen" @default.
- Q92029373 P304 "1505-1518" @default.
- Q92029373 P31 Q13442814 @default.
- Q92029373 P356 "10.1002/JCPH.1438" @default.
- Q92029373 P433 "11" @default.
- Q92029373 P478 "59" @default.
- Q92029373 P577 "2019-05-14T00:00:00Z" @default.
- Q92029373 P698 "31090092" @default.
- Q92029373 P921 Q323936 @default.
- Q92029373 P921 Q718753 @default.